+173%
Revenue Growth
We’ll build your custom roadmap to higher profit.
HemRid Amazon Case Study: +173% Revenue, +414% Profit, #3 in 9 Months
The Snapshot
At a Glance
Brand Profile
- Brand
- HemRid
- Category
- Health & Household, OTC Medication
- Catalog
- 24 SKUs
- Marketplace
- Amazon
- Timeframe
- 9 Months
- Focus
- Profit-first governance and market share
The Results
+414%
Profit Growth
#3
Category Position
24
SKUs Under Governance
Starting Condition17 months of flat revenue and stagnant profit. Reinvestment capacity constrained. A category dominated by entrenched pharma competitors.
Executive Summary
Executive Summary
HemRid had been stuck for 17 months. Revenue flat, profit stagnant, and the reinvestment capacity every scaling brand needs was gone. In an OTC category dominated by entrenched pharma competitors, the temptation was to spend harder. That would have made the problem worse.
The plateau was structural. When a brand flatlines that long, it is rarely a traffic or targeting issue. The operating model has run out of room, and more spend on a maxed-out system buys volatility, not share.
In 9 months: +173% revenue, +414% profit, and the #3 slot in a category run by pharma giants.
Adverio rebuilt HemRid's operating model as a market leadership engine. Profit-first SKU governance treated the 24-SKU catalog like a portfolio. Amazon and DSP scaled under strict unit economics. Google fed external demand into the ecosystem. Daily optimization loops compounded the gains.
Profit grew faster than revenue because the system protected margin at every scale point. The result is not a spike. It is a top-3 category position built on structural compounding.
The Objective
The Objective
Break the 17-month revenue plateau
Restore profit expansion so reinvestment could resume
Scale Amazon and DSP without breaking unit economics
Widen demand into Google as a controlled amplifier
Reach a top-3 position in a category run by pharma competitors
The Challenge
The Challenge
A 17-month plateau is not a traffic problem. It is not a targeting problem either. It is the operating model telling you it has hit its limit.
More spend on a maxed-out system buys volatility, not share.
Every additional dollar of ad spend without a structural change compounded the drag. Reinvestment capacity thinned. Profit stagnated. And in an OTC category where pharma competitors run at scale, standing still means losing ground.
HemRid did not need more spend. It needed a different way of running the account.
Diagnosis
Not a traffic problem
Not a targeting problem
A system saturation problem
The operating model had maxed out. The fix was structural: govern the catalog like a portfolio, fund what is provably incremental, and widen demand only where unit economics support it.
The System
Adverio's System: Market Leadership Engine
Four moves. One outcome: a maxed-out account turned into a compounding leadership engine.
We treated the 24-SKU catalog as a portfolio, not a set of campaigns. Each SKU got funded based on its contribution to profit, not raw volume. Growth drivers and margin drivers were separated so budget followed provable incrementality.
Profitability guardrails set the floor on every allocation. No SKU got more spend just because it moved units. It got more spend only if that spend produced incremental profit.
ResultCapital moved to what actually compounded. Margin freed for reinvestment.
Once governance was in place, we scaled reach. Amazon PPC restructured for non-branded expansion. DSP deployed for high-intent audience capture. Every channel ran under the same profitability floor, so wider reach never came at the cost of unit economics.
ResultControlled saturation across channels. Not isolated spend spikes.
Google as a Demand Amplifier
Google was not a separate marketing channel. It was a demand input layer feeding the Amazon ecosystem, injecting incremental branded and non-branded demand into the flywheel.
The upside is not obvious until you run it: when Amazon CPCs cap or auctions get contested, an external demand pipe lets you keep expanding at profitable rates. HemRid's growth compounded because we widened the demand pipe, we did not just fight for the same auctions.
ResultWhen Amazon capped, the pipe widened. Only where unit economics supported it.
Daily Optimization Loops
The account was operated like a compounding control system. Daily optimization. Continuous pruning of inefficiencies. Rapid reinvestment into proven growth pockets. Tight feedback between performance data and profit signal.
Leadership is not built on one big move. It is built on consistent correct decisions.
ResultThe system got sharper as it scaled. Compounding week over week.
HemRid was stuck for 17 months before a single lever moved. The constraint was structural. If your account keeps hitting the same number, the ceiling is not the market. It is your operating model.
Forecast My Amazon Growth 15-minute diagnostic. No pitch deck.The Results
The Results
+173%
Revenue Growth
In 9 months, breaking a 17-month plateau.
+414%
Profit Growth
Profit scaled faster than revenue. Reinvestment capacity restored.
#3
Category Position
Achieved top-3 standing in an OTC category dominated by pharma competitors.
24
SKUs Governed
Full portfolio scaled under a single profit-first system.
The Structural Recovery Result
From a 17-month plateau to top-3 category leadership in 9 months
Before
- Flat revenue for 17 months
- Profit stagnant, reinvestment blocked
- Losing ground to entrenched pharma
After
- +173% revenue in 9 months
- +414% profit, faster than topline
- #3 category position under governance
Same market, same category, same competitors. The operating model changed.
This was not a temporary spike. It was structural compounding. The system that produced the result is the system that keeps producing it.
The Lesson
The Lesson (For Operators)
Plateaus are not failures. They are signals. When a brand flatlines for a year and a half, the operating model has run out of room.
Growth without guardrails is volatility. Growth with governance is market share.
More spend on a maxed-out system does not scale the brand. It scales the volatility. The winners in every crowded category are the ones who govern the catalog like a portfolio, fund provable incrementality, and widen demand only where unit economics allow. Everyone else buys traffic and calls it growth.
HemRid's #3 position is not a marketing story. It is a governance story. When the system changed, the ceiling moved. That is the sequence worth remembering: system first, then scale.
The Verdict
HemRid was stuck for 17 months and moved into the top three in 9. What changed was the operating model, not the effort.
+173% revenue. +414% profit. #3 in category.
Governance is what turns growth into market share.
If your account is stuck at the same number quarter after quarter, the ceiling is a system signal. We map where the operating model has maxed out and what a rebuild would return.
Map My Market Leadership Plan 15-minute call. Zero obligation.FAQs
Frequently Asked Questions
Growth came from governance, not budget. Adverio reallocated spend to SKUs with provable incrementality, scaled controlled DSP demand capture, and used Google as a demand input layer. Profit grew 414% because the system protected margin at every scale point. Wider revenue on tighter unit economics is what a maxed-out account gets when the operating model changes.
It means treating the catalog like a portfolio. Each SKU is funded based on contribution to profit, not raw sales volume. Growth drivers and margin drivers are separated, and budget follows where incrementality is provable. That is how a 24-SKU portfolio scales without margin erosion.
Yes. HemRid reached the #3 position in an OTC category dominated by pharma competitors in 9 months. The constraint was never the competition. It was a maxed-out operating model. Once the system changed, the ceiling moved.
Quick Answer
HemRid broke a 17-month revenue plateau and reached #3 in an OTC category run by pharma giants, growing revenue 173% and profit 414% in 9 months. Adverio ran a market leadership engine across 24 SKUs: profit-first governance, Amazon and DSP scaling, Google as an external demand amplifier, and daily optimization loops. Growth came from the operating model, not the ad budget.
Similar Challenges and Results
Growth Recovered in 4 Months After 2 Quarters of Growth Decline
Product Category: Health & Household > Health Care > Over-the-Counter Medication (OTC)
Explore Case Study
Sunbird Organics – 10X Performance Gains in Just 4 Months
Category: Grocery & Gourmet Food > Natural & Organic Supplements
Explore Case Study
Tribe Organics – Doubling Sales With ACoS Optimization
Category: Health & Household > Natural Supplements
Explore Case Study